Sytheon Patents Isosorbide Esters for Skin Diseases, Enters Dermatological Market

Sytheon inventors have discovered certain esters of isosorbide can modify and regulate the expression of genes, genetic networks, and cellular pathways in the skin. The company has patented this invention for the dermatology market. Assigned to Sytheon, U.​S. Patent 10,597,402 discloses, “compositions and methods for restoring epidermal integrity and function and treating dermatol­ogical diseases.” According […]